Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

Research group Dynamics of early viral infection and the innate antiviral response

Headed by: Dr. Marco Binder

Dr. Marco Binder

IIC / ATV building, room 2.213

Phone: +49 6221 42-4974
Email: m.binder[at]

Our Interests

Infection mediated carcinogenesis can involve pathogen-encoded oncogenes (e.g. the human papilloma virus early genes E6/E7), but it always requires the establishment of a chronic/persistent infection. Even in the absence of classical oncogenes, long-term presence of antigens that lead to the development of an inflammatory environment within the host organ result in favorable conditions for the development of cancer (see the recent mini-review by Scott A. Read and Mark W. Douglas).

Our research group focuses on viral infections and strives to understand the primordial failure of the innate immune system to clear the virus. While our underlying goal is comprehending and ultimately interfering with the chronification of hepatitis C virus, we study the mechanisms behind pathogen recognition and subsequent antiviral signaling in the context of model viruses and systems that can be more stringently controlled. Our models include, amongst others, vesicular stomatitis virus (VSV), Rift valley fever virus (RVFV) or virus-free stimulation of the cellular antiviral system by transfection of ligand RNAs or constitutively active signaling molecules. With molecular and cellular biological and biochemical techniques we dissect the cellular pathways leading to the induction of type I and III interferons in addition to the proinflammatory system. We then apply modern systems biological approaches and mathematical modeling to integrate this knowledge into a comprehensive framework of interactions. This will be essential for the understanding of complex inter-dependencies between the virus and its host cell in the course of establishing a persistent infection and mounting of an inflammatory response, both being critical determinants for the eventual initiation of cancer development.

to top
powered by webEdition CMS